Acorda Therapeutics, Inc. News - ACOR

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Acorda Therapeutics, Inc. ACOR NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.195 2.59% 7.73 7.79 7.53 7.55 7.53 13:52:40
more quote information »

Recent News

Date Time Source Heading
6/17/20197:02IHNWPromotedThis Cannabis Company Increased Revenue by 1000%
6/03/201907:00BWAcorda Therapeutics Debuts Art Exhibition Inspired by People..
5/31/201916:12EDGARAmended Current Report Filing (8-k/a)
5/23/201909:06PRNUSWedbush Securities Senior Vice President of Equity Research..
5/23/201907:00BWAcorda Therapeutics to Present at Jefferies 2019 Healthcare..
5/07/201917:12EDGARQuarterly Report (10-q)
5/02/201906:21EDGARCurrent Report Filing (8-k)
5/02/201906:00BWAcorda Provides Update for First Quarter Ended March 31,..
4/26/201917:10EDGARProxy Statement (definitive) (def 14a)
4/18/201907:00BWAcorda First Quarter 2019 Update: Webcast/Conference Call..
3/19/201907:00BWAcorda to Present New Long-Term Data for INBRIJA™ (levodopa..
3/12/201916:27EDGARStatement of Changes in Beneficial Ownership (4)
3/12/201916:25EDGARStatement of Changes in Beneficial Ownership (4)
3/12/201916:23EDGARStatement of Changes in Beneficial Ownership (4)
3/12/201916:21EDGARStatement of Changes in Beneficial Ownership (4)
3/12/201916:17EDGARStatement of Changes in Beneficial Ownership (4)
3/12/201916:15EDGARStatement of Changes in Beneficial Ownership (4)
3/12/201916:12EDGARStatement of Changes in Beneficial Ownership (4)
3/08/201907:12EDGARCurrent Report Filing (8-k)
3/08/201907:00BWAcorda Therapeutics Announces Management Changes
3/06/201907:00BWAcorda to Present at Oppenheimer’s 29th Annual Healthcare..
2/28/201917:56EDGARCurrent Report Filing (8-k)
2/28/201916:00BWAcorda Therapeutics Announces Commercial Launch of INBRIJA™..
2/27/201917:13EDGARAnnual Report (10-k)
2/26/201907:00BWAcorda Therapeutics to Present at Cowen Annual Health Care..
2/25/201916:23EDGARStatement of Changes in Beneficial Ownership (4)
2/25/201916:21EDGARStatement of Changes in Beneficial Ownership (4)
2/25/201916:18EDGARStatement of Changes in Beneficial Ownership (4)
2/25/201916:14EDGARStatement of Changes in Beneficial Ownership (4)
2/19/201907:00BWAcorda Therapeutics to Present at Leerink Global Healthcare..
2/14/201918:26EDGARCurrent Report Filing (8-k)
2/14/201917:26EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201916:00BWAcorda Provides Financial and Pipeline Update for Fourth..
2/14/201908:37EDGARStatement of Ownership (sc 13g)
2/13/201911:46EDGARAmended Statement of Ownership (sc 13g/a)
2/11/201916:15EDGARAmended Statement of Ownership (sc 13g/a)
2/11/201911:16EDGARAmended Statement of Ownership (sc 13g/a)
2/08/201907:12EDGARAmended Statement of Ownership (sc 13g/a)
2/04/201907:12EDGARCurrent Report Filing (8-k)
2/04/201907:00BWAcorda Appoints Peter S. Carbone Senior Vice President,..
2/01/201916:30EDGARStatement of Changes in Beneficial Ownership (4)
2/01/201907:00BWAcorda Fourth Quarter/Year End 2018 Update..
1/28/201916:11EDGARStatement of Changes in Beneficial Ownership (4)
1/28/201906:27EDGARCurrent Report Filing (8-k)
1/24/201916:09EDGARStatement of Changes in Beneficial Ownership (4)
1/24/201913:49EDGARAmended Statement of Ownership (sc 13g/a)
1/23/201916:53EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/22/201916:20EDGARStatement of Changes in Beneficial Ownership (4)
1/18/201906:59EDGARCurrent Report Filing (8-k)
1/17/201918:30BWAcorda Announces The Lancet Neurology Publication of Phase 3..
1/17/201916:08EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »

Your Recent History
Acorda The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.